Anti-HID1 antibodies are used in the immunodetection of the protein HID1 domain containing. In humans, the canonical protein has a reported length of 788 amino acid residues and a mass of 88.7 kDa. Its subcellular localization is in the Golgi and cytoplasm. Up to 3 different isoforms have been reported for this protein. It is found to be expressed in the heart, skeletal muscle, colon, spleen, kidney, liver, small intestine and lung. A member of the Hid-1 protein family, Hid1 is believed to play an important role in the development of cancers in a broad range of tissues. The HID1 gene has been associated with the disease, Developmental and epileptic encephalopathy 105 with hypopituitarism. Synonyms for this target antigen include HID1 domain-containing protein, UPF0663 transmembrane protein C17orf28, down-regulated in multiple cancers 1, downregulated in multiple cancer 1, protein hid-1 homolog, and protein HID1. A number of Hid1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. Flow Cytometry, Immunofluorescence, and Immunohistochemistry are also common applications.